Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.75K Buy
+1,501
New +$4.84K ﹤0.01% 9038
2025
Q4
Sell
-9,762
Closed -$35.4K 10687
2025
Q3
$35.4K Sell
9,762
-598
-6% -$2.27K ﹤0.01% 7790
2025
Q2
$43.5K Sell
10,360
-3,260
-24% -$12.8K ﹤0.01% 7884
2025
Q1
$45.5K Buy
13,620
+9,914
+268% +$40.5K ﹤0.01% 7662
2024
Q4
$15.4K Buy
3,706
+2,676
+260% +$11.2K ﹤0.01% 8046
2024
Q3
$3.76K Hold
1,030
﹤0.01% 8224
2024
Q2
$4.94K Sell
1,030
-736
-42% -$4.13K ﹤0.01% 8036
2024
Q1
$13.8K Sell
1,766
-508
-22% -$4K ﹤0.01% 7085
2023
Q4
$26.7K Buy
2,274
+435
+24% +$4.27K ﹤0.01% 6923
2023
Q3
$18.2K Sell
1,839
-5,486
-75% -$64.5K ﹤0.01% 6857
2023
Q2
$82.8K Buy
7,325
+5,995
+451% +$64K ﹤0.01% 6157
2023
Q1
$13.9K Sell
1,330
-2,006
-60% -$19.2K ﹤0.01% 7374
2022
Q4
$27K Buy
3,336
+450
+16% +$3.94K ﹤0.01% 7351
2022
Q3
$26K Buy
2,886
+2,586
+862% +$30.8K ﹤0.01% 7042
2022
Q2
$4K Sell
300
-1,457
-83% -$19K ﹤0.01% 9058
2022
Q1
$27K Sell
1,757
-234
-12% -$4K ﹤0.01% 7097
2021
Q4
$47K Buy
+1,991
New +$46.4K ﹤0.01% 6961

Other funds holding EVO

UBS Group's EVO Position: Q1 2026 in Review

UBS Group opened a new position in Evotec (EVO) in Q1 2026: 1,501 shares worth $3.75K. The stake represents ﹤0.01% of the portfolio and ranks #9038 among its holdings. This is a return to the name: UBS Group previously reported a position in EVO as recently as Q3 2025.

UBS Group first reported a position in EVO in Q4 2021 and has held it in 17 quarters since. The position peaked at $82.8K in Q2 2023. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

  • UBS Group held 1,501 shares of Evotec worth $3.75K as of Q1 2026.
  • Evotec was a new UBS Group position in Q1 2026.
  • Evotec made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9038 holding.
  • UBS Group first reported a position in Evotec in Q4 2021 and has held it in 17 quarters since.
  • UBS Group's Evotec position peaked at $82.8K in Q2 2023.
  • 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.